Mental health: drug screening analysis for 150,000 government employees last year

Subscribe to receive the most important news

–
–

A delegation from the General Secretariat for Mental Health and Addiction Treatment participated in the national symposium on “The Global Annual Report on Drugs and the Impact of COVID-19 on Supply and Demand”, in partnership with the Egyptian Ministry of Foreign Affairs and the Ministry of Interior, which was held via the Internet.

During the symposium, international reports issued during the past year were reviewed, including the reports issued on the drug Tramadol, which Egypt had the honor to participate strongly in preparing.

It is known that the Secretariat oversees 19 hospitals and centers throughout the Republic, providing treatment to about 130,000 patients annually in the outpatient clinics, and about 6,000 patients annually in the internal departments.

The secretariat follows in its treatment policies the scientific programs proven by evidence and internationally approved by the largest parties concerned with treating addiction, and services have continued without interruption during the Corona pandemic, with the provision of services via the Internet in order to provide the necessary support for addiction patients during the crisis.

It also conducts an analysis of drug detection for workers in the government sector, hospitals and the private sector as a contribution to reducing the problem of addiction, as it was detected through campaigns on 150,000 employees in the state’s administrative apparatus during 2019, and it is also about to announce soon the results of a comprehensive national survey on the phenomenon of abuse. And addiction in Egypt.

It is known that the Municipality is training various cadres working in the field of addiction treatment and has graduated the first batch of recovery counselors and is currently training the second batch through the Internet, and it will soon announce the graduation ceremony of the first batch of doctors who have obtained the first clinical diploma in the treatment of addiction.